Earnings estimate | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
No. of analysts | 0 | 0 | 1 | 1 |
Avg. Estimate | 0 | 0 | 1.03 | 1.21 |
Low estimate | 0 | 0 | 1.03 | 1.21 |
High estimate | 0 | 0 | 1.03 | 1.21 |
Year ago EPS | N/A | N/A | 0.19 | 1.03 |
Revenue estimate | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
No. of analysts | 0 | 0 | 1 | 1 |
Avg. Estimate | N/A | N/A | 183M | 199M |
Low estimate | N/A | N/A | 183M | 199M |
High estimate | N/A | N/A | 183M | 199M |
Year ago sales | N/A | N/A | 163.01M | 183M |
Sales growth (year/est) | N/A | N/A | 12.30% | 8.70% |
Earnings history | Invalid Date | Invalid Date | Invalid Date | Invalid Date |
---|---|---|---|---|
Est. EPS | N/A | N/A | N/A | N/A |
Actual EPS | N/A | N/A | N/A | N/A |
Difference | N/A | N/A | N/A | N/A |
Surprise % | N/A | N/A | N/A | N/A |
EPS trend | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
Current estimate | 0 | 0 | 1.03 | 1.21 |
7 days ago | 0 | 0 | 1.03 | 1.21 |
30 days ago | 0 | 0 | 0.7 | 0.9 |
60 days ago | 0 | 0 | 0.7 | 0.9 |
90 days ago | 0 | 0 | 0.7 | 0.9 |
EPS revisions | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | N/A | N/A | 1 | 1 |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | N/A |
Growth estimates | ARCOMA.ST | Industry | Sector(s) | S&P 500 |
---|---|---|---|---|
Current qtr. | N/A | N/A | N/A | N/A |
Next qtr. | N/A | N/A | N/A | N/A |
Current year | 442.10% | N/A | N/A | N/A |
Next year | 17.50% | N/A | N/A | N/A |
Next 5 years (per annum) | N/A | N/A | N/A | N/A |
Past 5 years (per annum) | N/A | N/A | N/A | N/A |